Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China | |
Zhu, Zhenhua; Lv, Nonghua; Liu, Dongsheng; Chen, Shiyao; Zeng, Zhirong; Lu, Hong; Zhang, Zhenyu; Zhang, Lingxia; Wang, Jiangbin; Xie, Yong | |
刊名 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
2018 | |
卷号 | 62期号:9 |
ISSN号 | 0066-4804 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3512830 |
专题 | 吉林大学白求恩第三医院 |
推荐引用方式 GB/T 7714 | Zhu, Zhenhua,Lv, Nonghua,Liu, Dongsheng,et al. Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY,2018,62(9). |
APA | Zhu, Zhenhua.,Lv, Nonghua.,Liu, Dongsheng.,Chen, Shiyao.,Zeng, Zhirong.,...&Xie, Yong.(2018).Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China.ANTIMICROBIAL AGENTS AND CHEMOTHERAPY,62(9). |
MLA | Zhu, Zhenhua,et al."Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China".ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 62.9(2018). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论